Epidemiology, radiology, and genetics of nicotine dependence in COPD

Respiratory Research

Volumn 12, Issue , 2011, Pages

  Kim, Deog Kyeom ^a,b   Hersh, Craig P ^a   Washko, George R ^a   Hokanson, John E ^c   Lynch, David A ^d   Newell, John D ^d   Murphy, James R ^d   Crapo, James D ^d   Silverman, Edwin K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Seoul National University Boramae Hospital   (South Korea)

^c Global Health and Health Disparities   (United States)

^d DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRNA3 PROTEIN; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG; CHRNA3 PROTEIN, HUMAN; CHRNA5 PROTEIN, HUMAN; NERVE PROTEIN;

ADULT; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PHENOTYPE; PROSPECTIVE STUDY; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; THORAX RADIOGRAPHY; TOBACCO DEPENDENCE; VOLUMETRY; AGED; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FORCED EXPIRATORY VOLUME; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RADIOGRAPHY; RISK ASSESSMENT; RISK FACTOR; SPIROMETRY; STATISTICAL MODEL; UNITED STATES;

AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RECEPTORS, NICOTINIC; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY; TOBACCO USE DISORDER; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 78651287137     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-9     Document Type: Article

References (45)

1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007, 370(9589):765-773. 10.1016/S0140-6736(07)61380-4, 17765526.
2. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977, 1(6077):1645-1648. 10.1136/bmj.1.6077.1645, 1607732, 871704.
3. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176(6):532-555. 10.1164/rccm.200703-456SO, 17507545.
4. Tashkin DP, Celli B, Kesten S, Lystig T, Mehra S, Decramer M. Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial. Eur Respir J 2010, 35(2):287-294. 10.1183/09031936.00082909, 19717481.
5. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003, 58(2):100-105. 10.1136/thorax.58.2.100, 1746561, 12554887.
6. Au DH, Bryson CL, Chien JW, Sun H, Udris EM, Evans LE, Bradley KA. The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J Gen Intern Med 2009, 24(4):457-463. 10.1007/s11606-009-0907-y, 2659150, 19194768.
7. Heijdra YF, Pinto-Plata VM, Kenney LA, Rassulo J, Celli BR. Cough and phlegm are important predictors of health status in smokers without COPD. Chest 2002, 121(5):1427-1433. 10.1378/chest.121.5.1427, 12006424.
8. Bellomi M, Rampinelli C, Veronesi G, Harari S, Lanfranchi F, Raimondi S, Maisonneuve P. Evolution of emphysema in relation to smoking. Eur Radiol 20(2):286-292. 10.1007/s00330-009-1548-6, 19705126.
9. Minai OA, Benditt J, Martinez FJ. Natural history of emphysema. Proc Am Thorac Soc 2008, 5(4):468-474. 10.1513/pats.200802-018ET, 2645321, 18453357.
10. Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 2009, 49:57-71. 10.1146/annurev.pharmtox.48.113006.094742, 2946180, 18834313.
11. Stevens VL, Bierut LJ, Talbot JT, Wang JC, Sun J, Hinrichs AL, Thun MJ, Goate A, Calle EE. Nicotinic receptor gene variants influence susceptibility to heavy smoking. Cancer Epidemiol Biomarkers Prev 2008, 17(12):3517-3525. 10.1158/1055-9965.EPI-08-0585, 2614129, 19029397.
12. Han MK, Bartholmai B, Liu LX, Murray S, Curtis JL, Sciurba FC, Kazerooni EA, Thompson B, Frederick M, Li D, et al. Clinical significance of radiologic characterizations in COPD. COPD 2009, 6(6):459-467. 10.3109/15412550903341513, 19938970.
13. Lee YK, Oh YM, Lee JH, Kim EK, Kim N, Seo JB, Lee SD. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008, 186(3):157-165. 10.1007/s00408-008-9071-0, 18351420.
14. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, Feng S, Hersh CP, Bakke P, Gulsvik A, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009, 5(3):e1000421. 10.1371/journal.pgen.1000421, 2650282, 19300482.
15. Li MD. Identifying susceptibility loci for nicotine dependence: 2008 update based on recent genome-wide linkage analyses. Hum Genet 2008, 123(2):119-131. 10.1007/s00439-008-0473-0, 18205015.
16. Galvan A, Dragani TA. Nicotine dependence may link the 15q25 locus to lung cancer risk. Carcinogenesis 2010, 31(3):331-333. 10.1093/carcin/bgp282, 19910382.
17. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008, 452(7187):638-642. 10.1038/nature06846, 18385739.
18. Lambrechts D, Buysschaert I, Zanen P, Coolen J, Lays N, Cuppens H, Groen HJ, Dewever W, van Klaveren RJ, Verschakelen J, et al. The 15q24/25 Susceptibility Variant for Lung Cancer and COPD is Associated with Emphysema. Am J Respir Crit Care Med 2010, 181(5):486-493. 10.1164/rccm.200909-1364OC, 20007924.
19. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD. Genetic epidemiology of COPD (COPDGene) study design. COPD 7(1):32-43. 10.3109/15412550903499522, 20214461.
20. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991, 86(9):1119-1127. 10.1111/j.1360-0443.1991.tb01879.x, 1932883.
21. Fagerstrom KO, Kunze M, Schoberberger R, Breslau N, Hughes JR, Hurt RD, Puska P, Ramstrom L, Zatonski W. Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control 1996, 5(1):52-56. 10.1136/tc.5.1.52, 1759482, 8795860.
22. Patel BD, Coxson HO, Pillai SG, Agusti AG, Calverley PM, Donner CF, Make BJ, Muller NL, Rennard SI, Vestbo J, et al. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 178(5):500-505. 10.1164/rccm.200801-059OC, 18565956.
23. Washko GR, Martinez FJ, Hoffman EA, Loring SH, Estepar RS, Diaz AA, Sciurba FC, Silverman EK, Han MK, Decamp M, et al. Physiological and computed tomographic predictors of outcome from lung volume reduction surgery. Am J Respir Crit Care Med 181(5):494-500. 10.1164/rccm.200906-0911OC, 19965810.
24. Nakano Y, Wong JC, de Jong PA, Buzatu L, Nagao T, Coxson HO, Elliott WM, Hogg JC, Pare PD. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 2005, 171(2):142-146. 10.1164/rccm.200407-874OC, 15516531.
25. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008, 40(5):616-622. 10.1038/ng.109, 2713680, 18385676.
26. Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Hersh CP, DeMeo DL, Hunninghake GM, Litonjua AA, Sparrow D, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 42(3):200-202. 10.1038/ng.535, 2828499, 20173748.
27. Park SM, Son KY, Lee YJ, Lee HC, Kang JH, Chang YJ, Yun YH. A preliminary investigation of early smoking initiation and nicotine dependence in Korean adults. Drug Alcohol Depend 2004, 74(2):197-203. 10.1016/j.drugalcdep.2004.01.001, 15099663.
28. Breslau N, Fenn N, Peterson EL. Early smoking initiation and nicotine dependence in a cohort of young adults. Drug Alcohol Depend 1993, 33(2):129-137. 10.1016/0376-8716(93)90054-T, 8261877.
29. Dasgupta P, Kinkade R, Joshi B, Decook C, Haura E, Chellappan S. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci USA 2006, 103(16):6332-6337. 10.1073/pnas.0509313103, 1458878, 16601104.
30. Cucina A, Fuso A, Coluccia P, Cavallaro A. Nicotine inhibits apoptosis and stimulates proliferation in aortic smooth muscle cells through a functional nicotinic acetylcholine receptor. J Surg Res 2008, 150(2):227-235. 10.1016/j.jss.2007.10.019, 18295799.
31. Riveles K, Huang LZ, Quik M. Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells. Neurotoxicology 2008, 29(3):421-427. 10.1016/j.neuro.2008.02.001, 2486261, 18359086.
32. Perez-Rios M, Santiago-Perez MI, Alonso B, Malvar A, Hervada X, de Leon J. Fagerstrom test for nicotine dependence vs heavy smoking index in a general population survey. BMC Public Health 2009, 9:493. 10.1186/1471-2458-9-493, 2809067, 20042106.
33. Vozoris NT, Stanbrook MB. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir Med 2010,
34. Sundblad BM, Larsson K, Nathell L. High rate of smoking abstinence in COPD patients: Smoking cessation by hospitalization. Nicotine Tob Res 2008, 10(5):883-890. 10.1080/14622200802023890, 18569763.
35. Berger P, Laurent F, Begueret H, Perot V, Rouiller R, Raherison C, Molimard M, Marthan R, Tunon-de-Lara JM. Structure and function of small airways in smokers: relationship between air trapping at CT and airway inflammation. Radiology 2003, 228(1):85-94. 10.1148/radiol.2281020187, 12750458.
36. Lams BE, Sousa AR, Rees PJ, Lee TH. Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 158(5 Pt 1):1518-1523.
37. Lapperre TS, Postma DS, Gosman MM, Snoeck-Stroband JB, ten Hacken NH, Hiemstra PS, Timens W, Sterk PJ, Mauad T. Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax 2006, 61(2):115-121. 10.1136/thx.2005.040519, 2104584, 16055612.
38. Camiciottoli G, Cavigli E, Grassi L, Diciotti S, Orlandi I, Zappa M, Picozzi G, Pegna AL, Paci E, Falaschi F, et al. Prevalence and correlates of pulmonary emphysema in smokers and former smokers. A densitometric study of participants in the ITALUNG trial. Eur Radiol 2009, 19(1):58-66. 10.1007/s00330-008-1131-6, 18690451.
39. Lederer DJ, Enright PL, Kawut SM, Hoffman EA, Hunninghake G, van Beek EJ, Austin JH, Jiang R, Lovasi GS, Barr RG. Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. Am J Respir Crit Care Med 2009, 180(5):407-414. 10.1164/rccm.200812-1966OC, 2742759, 19542480.
40. Washko GR, Lynch DA, Matsuoka S, Ross JC, Umeoka S, Diaz A, Sciurba FC, Hunninghake GM, San Jose Estepar R, Silverman EK, et al. Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol 17(1):48-53. 10.1016/j.acra.2009.07.016, 2790552, 19781963.
41. Saccone NL, Wang JC, Breslau N, Johnson EO, Hatsukami D, Saccone SF, Grucza RA, Sun L, Duan W, Budde J, et al. The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res 2009, 69(17):6848-6856. 10.1158/0008-5472.CAN-09-0786, 2874321, 19706762.
42. Chen X, Chen J, Williamson VS, An SS, Hettema JM, Aggen SH, Neale MC, Kendler KS. Variants in nicotinic acetylcholine receptors alpha5 and alpha3 increase risks to nicotine dependence. Am J Med Genet B Neuropsychiatr Genet 2009, 150B(7):926-933. 10.1002/ajmg.b.30919, 19132693.
43. Le Marchand L, Derby KS, Murphy SE, Hecht SS, Hatsukami D, Carmella SG, Tiirikainen M, Wang H. Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Cancer Res 2008, 68(22):9137-9140. 10.1158/0008-5472.CAN-08-2271, 2587068, 19010884.
44. Monsees GM, Tamimi RM, Kraft P. Genome-wide association scans for secondary traits using case-control samples. Genet Epidemiol 2009, 33(8):717-728. 10.1002/gepi.20424, 2790028, 19365863.
45. Lin DY, Zeng D. Proper analysis of secondary phenotype data in case-control association studies. Genet Epidemiol 2009, 33(3):256-265. 10.1002/gepi.20377, 2684820, 19051285.